Ulla Aspenblad

626 total citations
13 papers, 510 citations indexed

About

Ulla Aspenblad is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Ulla Aspenblad has authored 13 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology and Allergy. Recurrent topics in Ulla Aspenblad's work include Cell Adhesion Molecules Research (5 papers), Cancer-related Molecular Pathways (3 papers) and Prostate Cancer Treatment and Research (3 papers). Ulla Aspenblad is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Cancer-related Molecular Pathways (3 papers) and Prostate Cancer Treatment and Research (3 papers). Ulla Aspenblad collaborates with scholars based in Sweden, United States and Australia. Ulla Aspenblad's co-authors include Gert Auer, Catharina Larsson, Sirpa Salo, Karl Tryggvason, E. Eriksson, Birgitta Moberger, Barbro Skyldberg, Birgitta Sundelin, Elina Eriksson and Ulf S.R. Bergerheim and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Oncogene and British Journal of Cancer.

In The Last Decade

Ulla Aspenblad

13 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulla Aspenblad Sweden 11 199 181 120 114 92 13 510
Lambert J. C. M. Van den Broek Netherlands 11 173 0.9× 126 0.7× 75 0.6× 195 1.7× 42 0.5× 14 543
H. Neumann Germany 8 259 1.3× 46 0.3× 94 0.8× 170 1.5× 79 0.9× 9 402
Paulisally Hau Yi Lo United States 18 448 2.3× 178 1.0× 242 2.0× 92 0.8× 39 0.4× 20 695
Roberta Merola Italy 14 247 1.2× 194 1.1× 184 1.5× 182 1.6× 22 0.2× 29 580
Christine To Canada 9 391 2.0× 323 1.8× 196 1.6× 173 1.5× 32 0.3× 11 708
Arthur A. Glatfelter United States 10 218 1.1× 114 0.6× 80 0.7× 324 2.8× 28 0.3× 14 615
Paul Perrotte Canada 7 284 1.4× 216 1.2× 179 1.5× 70 0.6× 42 0.5× 12 552
Philip G. Hargreaves United Kingdom 8 126 0.6× 86 0.5× 110 0.9× 88 0.8× 183 2.0× 12 608
Martin Judex Germany 11 147 0.7× 110 0.6× 44 0.4× 29 0.3× 38 0.4× 19 477
Brunhilde Chaloupka Germany 13 155 0.8× 282 1.6× 140 1.2× 26 0.2× 85 0.9× 14 482

Countries citing papers authored by Ulla Aspenblad

Since Specialization
Citations

This map shows the geographic impact of Ulla Aspenblad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulla Aspenblad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulla Aspenblad more than expected).

Fields of papers citing papers by Ulla Aspenblad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulla Aspenblad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulla Aspenblad. The network helps show where Ulla Aspenblad may publish in the future.

Co-authorship network of co-authors of Ulla Aspenblad

This figure shows the co-authorship network connecting the top 25 collaborators of Ulla Aspenblad. A scholar is included among the top collaborators of Ulla Aspenblad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulla Aspenblad. Ulla Aspenblad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Stoltzfus, Patricia, Sirpa Salo, Elina Eriksson, et al.. (2004). Laminin-5 γ2 Chain Expression Facilitates Detection of Invasive Squamous Cell Carcinoma of the Uterine Cervix. International Journal of Gynecological Pathology. 23(3). 215–222. 13 indexed citations
2.
Stoltzfus, Patricia, Anders Högmo, Johan Lindholm, et al.. (2004). The gamma2 chain of laminin-5 as an indicator of increased risk for recurrence in T1 stage tongue cancer.. PubMed. 24(5B). 3109–14. 6 indexed citations
3.
Hellman, Kristina, Ann‐Cathrin Hellström, Claes Silfverswärd, et al.. (2000). Cancer of the vagina: Laminin-5gamma2 chain expression and prognosis. International Journal of Gynecological Cancer. 10(5). 391–396. 19 indexed citations
4.
Skyldberg, Barbro, Sirpa Salo, E. Eriksson, et al.. (1999). Laminin-5 as a Marker of Invasiveness in Cervical Lesions. JNCI Journal of the National Cancer Institute. 91(21). 1882–1887. 130 indexed citations
5.
Li, Chunde, Geert Berx, Catharina Larsson, et al.. (1999). Distinct deleted regions on chromosome segment 16q23–24 associated with metastases in prostate cancer. Genes Chromosomes and Cancer. 24(3). 175–182. 3 indexed citations
6.
Farnebo, Filip, Gert Auer, Lars‐Ove Farnebo, et al.. (1999). Evaluation of Retinoblastoma and Ki‐67 Immunostaining as Diagnostic Markers of Benign and Malignant Parathyroid Disease. World Journal of Surgery. 23(1). 68–74. 61 indexed citations
7.
Li, Chunde, Geert Berx, Catharina Larsson, et al.. (1999). Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer. Genes Chromosomes and Cancer. 24(3). 175–182. 40 indexed citations
8.
Li, Chunde, Catharina Larsson, P. Andrew Futreal, et al.. (1998). Identification of two distinct deleted regions on chromosome 13 in prostate cancer. Oncogene. 16(4). 481–487. 74 indexed citations
9.
Linder, Stig, et al.. (1998). Evaluation of tissue and serum VEGF in patients with head and neck carcinoma. Angiogenesis. 2(4). 365–372. 11 indexed citations
10.
Linder, C., Georg Engel, Gert Auer, et al.. (1998). Correlation between basic fibroblast growth factor immunostaining of stromal cells and stromelysin-3 mRNA expression in human breast carcinoma. British Journal of Cancer. 77(6). 941–945. 13 indexed citations
11.
Aspenblad, Ulla, et al.. (1997). The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma. European Journal of Cancer. 33(11). 1799–1804. 34 indexed citations
12.
Larsson, Catharina, Göran Wallin, Martin Bäckdahl, et al.. (1996). Alterations of p53 and Expression of WAF1/p21 in Human Thyroid Tumors. Thyroid. 6(1). 1–9. 61 indexed citations
13.
Eriksson, Elina, H. Schimmelpenning, Ulla Aspenblad, Anders Zetterberg, & Gert Auer. (1994). Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease. Human Pathology. 25(11). 1228–1233. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026